DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹13,977 Cr | ₹12,559 Cr | ₹11,812 Cr | ₹10,558 Cr | ₹7,779 Cr |
What is the latest Appropriations of DIVIS LABORATORIES ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹13,977 Cr |
| Mar2024 | ₹12,559 Cr |
| Mar2023 | ₹11,812 Cr |
| Mar2022 | ₹10,558 Cr |
| Mar2021 | ₹7,779 Cr |
How is Appropriations of DIVIS LABORATORIES Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹13,977 Cr | 11.29 | |
| Mar2024 | ₹12,559 Cr | 6.32 | |
| Mar2023 | ₹11,812 Cr | 11.88 | |
| Mar2022 | ₹10,558 Cr | 35.73 | |
| Mar2021 | ₹7,779 Cr | - | |
Compare Appropriations of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹176,825.7 Cr | 0.1% | -2.5% | -0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,667.0 Cr | 1.4% | -4.5% | 6.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,554.0 Cr | -2.7% | 1.2% | 39.3% | Stock Analytics | |
| CIPLA | ₹109,120.0 Cr | -2.3% | -5.3% | -9.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,920.0 Cr | -0.5% | -4.7% | -5.4% | Stock Analytics | |
| MANKIND PHARMA | ₹97,611.6 Cr | -0.3% | -5.3% | -0.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 0.1% |
-2.5% |
-0.1% |
| SENSEX | 4.3% |
2.6% |
-6.4% |
You may also like the below Video Courses